Background. Rapid and early emergence of clinically significant LAM resistance is thought to be unlikely during the first year of treatment. and as a result LAM is thought to be a reasonable choice as a first line agent for prophylaxis during chemotherapy. Aim. https://spencertifieders.shop/product-category/antenna/